CONTRACTAPPROVED

The University of Texas System | State of Texas Awards $170,500,000 Supplies Contract to Genetix Biotherapeutics Inc (November 2026)

The University of Texas System | State of Texas logoThe University of Texas System | State of Texas
Disclosed value
$170,500,000
From agendapacket
Approved
Nov 14, 2026
Renews
Free account

The 30-second brief

What it covers

U.T. Southwestern approved a $170.5 million agreement with Genetix Biotherapeutics for specialty gene therapy products. The agreement covers treatment products for sickle cell-related diseases and automatically renews annually unless terminated with 30 days' notice.

Who holds it

Genetix Biotherapeutics Inc holds this supplies contract with The University of Texas System | State of Texas.

What happens next

The renewal date is on record. Get free alerts for pre-RFPs like this one, matched to what you sell.

Renewal date on recordLocked

Get pre-RFPs for work like this before the bid is out.

Get pre-RFP alerts free

Free account · 30-second setup · No credit card

Contract details

Contract type
Supplies
Amount
$170,500,000
Document date
November 14, 2026
Term
October 6, 2026 through October 5, 2027; automatic one-year renewal terms
Renews
On record
Source document
U.T. System Board of Regents Agenda Packet 2026-11-18 (AgendaPacket)

Genetix Biotherapeutics Inc's other public contracts

More The University of Texas System | State of Texas contracts

Questions about this contract

Who was awarded the supplies contract by The University of Texas System | State of Texas?

Genetix Biotherapeutics Inc was awarded this supplies contract by The University of Texas System | State of Texas, as recorded on November 14, 2026. The contract value is $170,500,000.

How much is the Genetix Biotherapeutics Inc contract with The University of Texas System | State of Texas worth?

The Genetix Biotherapeutics Inc contract with The University of Texas System | State of Texas is valued at $170,500,000, covering supplies work.

What type of contract is this?

This is a Supplies contract, documented as a agendapacket record.

Where was this contract approved?

This contract appears in U.T. System Board of Regents Agenda Packet 2026-11-18 (AgendaPacket), dated November 14, 2026 from The University of Texas System | State of Texas. Civic IQ extracts contract records directly from agency meeting documents and solicitations.

Show 2 more questions

What other contracts does Genetix Biotherapeutics Inc hold?

Genetix Biotherapeutics Inc may hold additional government contracts. View their full contract history, the agencies they serve, and total tracked spend on their Civic IQ vendor profile.

What is The University of Texas System | State of Texas currently buying?

Explore The University of Texas System | State of Texas's vendors, signed contracts, and active RFPs on their Civic IQ agency profile.

Work in government? Get Civic IQ free →

The coverage behind every signal

agencies covered
275,000+agencies covered
buying signals a week
400,000+buying signals a week
decision makers
2.6M+decision makers
in government spend tracked
$14T+in government spend tracked

Trusted by 200+ enterprise teams

Motive logoVeritone logoTerraCycle logoCyvl logoWithersRavenel logoDerivita logoSafeTouch logoIANS Research logoSewerAI logoProdigy Education logoEPR Fireworks logoFlow Labs logoCloudpermit logoMotive logoVeritone logoTerraCycle logoCyvl logoWithersRavenel logoDerivita logoSafeTouch logoIANS Research logoSewerAI logoProdigy Education logoEPR Fireworks logoFlow Labs logoCloudpermit logoMotive logoVeritone logoTerraCycle logoCyvl logoWithersRavenel logoDerivita logoSafeTouch logoIANS Research logoSewerAI logoProdigy Education logoEPR Fireworks logoFlow Labs logoCloudpermit logoMotive logoVeritone logoTerraCycle logoCyvl logoWithersRavenel logoDerivita logoSafeTouch logoIANS Research logoSewerAI logoProdigy Education logoEPR Fireworks logoFlow Labs logoCloudpermit logo